A new coalition of Canadian health-care workers is hoping to "revolutionize" frostbite care in Canada, in part by promoting a ...

Regulating drug discovery and pharmaceutical manufacturing, the FDA ensures the safety and effectiveness of innovative ...

Matica Biotechnology established a CDMO partnership with KaliVir Immunotherapeutics. SERB Pharmaceuticals acquired Aurlumyn (iloprost IV) from CiVi Biopharma. Eye drop maker Ocuphire Pharma and ...

The number of amputations due to frostbite in Edmonton reached 110 last winter, the highest level in more than a decade, according to new data obtained by CBC News. But Calgary marked its second ...

The number of amputations due to frostbite in Edmonton reached 110 last winter, the highest level in more than a decade, ...

Philadelphia, PA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of Aurlumyn ™ (iloprost IV), the only FDA approved ...

Philadelphia, USA-based SERB Pharmaceuticals has announced the acquisition of Aurlumyn (iloprost), the only Food and Drug Administration (FDA)-approved treatment for severe frostbite in the USA.

Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA ...